Shawn Scranton, PharmD
2019
In 2019, Shawn Scranton, PharmD earned a total compensation of $487.9K as Chief Operating Officer at Pfenex.
Compensation breakdown
| Non-Equity Incentive Plan | $138,338 |
|---|---|
| Option Awards | $46,644 |
| Salary | $295,538 |
| Other | $7,423 |
| Total | $487,943 |
PharmD received $295.5K in salary, accounting for 61% of the total pay in 2019.
PharmD also received $138.3K in non-equity incentive plan, $46.6K in option awards and $7.4K in other compensation.
Rankings
In 2019, Shawn Scranton, PharmD's compensation ranked 11,831st out of 13,971 executives tracked by ExecPay. In other words, PharmD earned more than 15.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,831 out of 13,971 | 15th |
Division Manufacturing | 4,792 out of 5,701 | 16th |
Major group Chemicals And Allied Products | 1,891 out of 2,200 | 14th |
Industry group Drugs | 1,629 out of 1,886 | 14th |
Industry Pharmaceutical Preparations | 1,209 out of 1,398 | 14th |
Source: SEC filing on April 1, 2020.
PharmD's colleagues
We found four more compensation records of executives who worked with Shawn Scranton, PharmD at Pfenex in 2019.